RIABNI
Live / Registered — Registered (as of 02 Aug 2022)
What this means for you
Registered since 02 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88182290
- Registration number
- 6809212
- Mark type
- Stylized text
- Filed
- 05 Nov 2018
- Published for opposition
- 10 Sept 2019
- Registered
- 02 Aug 2022
- Attorney of record
- Elsa D. Lemoine
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of inflammatory and auto-immune diseases and disorders; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), and microscopic polyangiitis (MPA)
Owner
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Feb 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Feb 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 02 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 25 Jun 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jun 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 Jun 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 16 Jun 2022 — USE AMENDMENT FILED
- 16 Jun 2022 — TEAS STATEMENT OF USE RECEIVED
- 03 May 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2022 — SOU EXTENSION 5 GRANTED
- 26 Apr 2022 — SOU EXTENSION 5 FILED